WebJun 27, 2024 · TRIM37 is part of the 17q23 amplicon present in approximately 18% of breast cancer tumors ( Kallioniemi et al., 1994) and overexpression of TRIM37 in these lines renders them sensitive to the PLK4 inhibitor centrinone ( Yeow et al., 2024; Meitinger et al., 2024 ). TRIM37 interacts with PLK4 and CEP192 ( Meitinger et al., 2024 ). WebJul 1, 2024 · TRIM37 deletion restored the ability of cells to proliferate in centrinone. Thus, centrosome removal via Plk4 inhibition appears to be a promising strategy for therapeutic treatment of neuroblastomas and potentially other …
TRIM37 controls cancer-specific vulnerability to PLK4
WebJan 25, 2024 · TRIM37 is an E3 ubiquitin ligase mutated in Mulibrey nanism, a disease with impaired organ growth and increased tumor formation. TRIM37 depletion from tissue … WebAug 5, 2024 · Serine/threonine-protein kinase polo-like kinase 4 (PLK4) is a mitosis-associated protein kinase that plays a vital role in the duplication of centrioles in dividing cells and is considered a promising target of synthetic lethality in TRIM37-amplified breast cancer. Herein, based on a rational drug … sonoma patchwork cable pullover
TRIM37 prevents formation of centriolar protein assemblies by ...
WebFeb 26, 2024 · TRIM37 controls cancer-specific vulnerability to PLK4 inhibition. A cis-eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma. LncRNA SNHG1 contributes to tumorigenesis and mechanism by targeting miR-338-3p to regulate PLK4 in human neuroblastoma. WebSep 9, 2024 · TRIM37 prevents PLK4 condensation We next investigated why reducing TRIM37 levels improves acentrosomal mitosis, whereas increasing TRIM37 levels … WebSep 9, 2024 · The researchers studied the genes encoded in the highly copied region and found a gene that was producing high levels of a protein -- TRIM37 -- shown to control centrosomes. Next, the researchers... sonoma neck warmer